What is the Comprehensive CGx Panel?
The Comprehensive Cancer Panel is a powerful tool designed to assess the genetic factors associated with hereditary cancers, including breast cancer, ovarian cancer, colon cancer, prostate cancer, melanoma, and other inherited cancers. The panel looks for genetic mutations or variants passed down through generations that have been linked to increased risks for these cancers. By understanding your genetic disposition, this testing provides valuable insights that can help you plan for the future, personalize your healthcare approach, and take proactive steps in managing your health.
How Will I Benefit?
To effectively treat cancer, it’s crucial to first identify its origin and type. Without knowing these details, treatment can feel uncertain. Certain genetic variants are known to increase the risk of specific cancers, and understanding these risks can be instrumental in prevention and treatment. Early detection is a cornerstone of successful cancer treatment, and identifying hereditary cancer risks can lead to more frequent screenings, tailored surveillance, and preventive measures to better manage your cancer risk. By pinpointing the exact gene involved, you can avoid unnecessary follow-up procedures and ensure more focused medical management. If a pathogenic variant is found, it’s not just important for you—it can have implications for close family members, who may share a 50% increased risk of developing the same type of cancer. In some instances, screening for these conditions may even be recommended for children.
What We Offer
Comprehensive Cancer Testing offers a deep dive into your genetic predisposition to a range of hereditary cancers. The Comprehensive Cancer Panel examines 193 genes that are associated with an increased risk for various cancers, such as breast cancer, ovarian cancer, colon cancer, prostate cancer, melanoma, and other inherited cancers. By studying inherited genetic mutations or variants, we can identify individuals who may have a higher likelihood of developing these cancers in their lifetime.
The primary objective of Comprehensive Cancer Testing is to provide you with critical information about your genetic makeup, allowing you to make informed decisions about your health and future. By gaining a clear understanding of your genetic risks, you can take steps toward preventive care, customize your healthcare strategies, and make well-informed decisions that can positively influence your long-term health outcomes.
Early detection and diagnosis of cancer are crucial for improving treatment outcomes, and this testing is a key tool in enhancing those efforts. Identifying specific genetic mutations linked to cancer risk can provide valuable data to help prevent and treat cancer more effectively. With early detection, there’s a higher chance of timely intervention, better screening, and personalized preventive care. If genetic testing indicates a hereditary cancer susceptibility, increased monitoring and proactive measures such as regular screenings may be advised to catch potential issues early.
Additionally, discovering a pathogenic variant in your genes can have implications for your immediate family members, as they may share up to a 50% increased risk of developing the same cancer. In certain situations, early screenings may even be recommended for children or siblings who are at risk. By understanding these genetic factors, you can take control of your health and make strategic decisions that benefit both you and your loved ones.